Ashkenazi Anat, EVP & CFO, has engaged in a series of transactions across two companies, Alphabet Inc. (GOOGL) and Eli Lilly and Company (LLY), as disclosed in SEC Form 4 filings. Over the course of 25 trades, Anat has demonstrated a clear bias toward selling, with total sell values significantly outweighing buy values. Specifically, the total buy value amounts to $3,103,864.60, while the total sell value reaches $12,770,360.51. Notably, all recent trades involve Alphabet Inc., with no recent buying activity reported.
The transactions in Alphabet Inc. primarily consist of sales, with significant sell values recorded on multiple dates. For instance, on December 25, 2025, Anat sold shares worth $2,140,242.60 and $3,725,221.67. Similarly, on September 25, 2025, sales totaled $1,679,048.25 and $2,922,659.19. These transactions suggest a consistent pattern of reducing holdings in Alphabet Inc. In contrast, the only notable buy activity occurred on February 12, 2024, when Anat acquired shares in Eli Lilly and Company valued at $3,103,864.60. This divergence in activity between the two companies underscores a strategic focus on Alphabet Inc. for divestment, while maintaining a smaller, singular investment in Eli Lilly and Company. The absence of recent trades indicates a pause in Anat’s trading activity as of the latest filings.
AI-assisted summary